Contact Information
Boston, MAPhone: 617-726-2000
Boston, MAPhone: 617-724-3874
About Bethany-Rose Daubman, MD
Bethany-Rose Daubman, MD received her medical degree with a Distinction in Bioethics from Albany Medical College. She completed residency and served as chief resident through the Tufts Family Medicine Residency, and completed her fellowship at Massachusetts General Hospital through the Harvard Palliative Medicine Fellowship. Her interests include resident and medical student education, reflective writing in medicine, and international palliative care.
Treats:
- Adult
Locations
Mass General Medicine: Inpatient Palliative Care
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2000
Mass General Medicine Unit
55 Fruit St.
Boston, MA 02114
Phone: 617-724-3874
Medical Education
- MD, Albany Medical College
- Residency, Tufts Family Medicine Residency at Cambridge Health Alliance
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Family Medicine, American Board of Family Medicine
- Hospice and Palliative Medicine, American Board of Family Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Reviews: Comments and Ratings
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.